Search results for the GEO ID: GSE32280
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM799722
GPL570
MDD patient 3 before treatment MDD patient 3 before treatment tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: before treatment CB2007224-D3A.CEL MDD patient 3 before treatment with venlafaxine
GSM799723
GPL570
MDD patient 4 before treatment MDD patient 4 before treatment tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: before treatment CB2007224-D4A.CEL MDD patient 4 before treatment with venlafaxine
GSM799724
GPL570
MDD patient 1 before treatment MDD patient 1 before treatment tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: before treatment CB2007224-D1A.CEL MDD patient 1 before treatment with venlafaxine
GSM799725
GPL570
MDD patient 2 before treatment MDD patient 2 before treatment tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: before treatment CB2007224-D2A.CEL MDD patient 2 before treatment with venlafaxine
GSM799726
GPL570
MDD patient 5 before treatment MDD patient 5 before treatment tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: before treatment CB2007224-D5A.CEL MDD patient 5 before treatment with venlafaxine
GSM799727
GPL570
health control 1 health control 1 tissue: peripheral blood cell type: lymphocytes disease status: healthy control CB2007224-C1.CEL health control 1
GSM799728
GPL570
health control 2 health control 2 tissue: peripheral blood cell type: lymphocytes disease status: healthy control CB2007224-C2.CEL health control 2
GSM799729
GPL570
health control 3 health control 3 tissue: peripheral blood cell type: lymphocytes disease status: healthy control CB2007224-C3.CEL health control 3
GSM799730
GPL570
health control 4 health control 4 tissue: peripheral blood cell type: lymphocytes disease status: healthy control CB2007224-C4.CEL health control 4
GSM799731
GPL570
health control 5 health control 5 tissue: peripheral blood cell type: lymphocytes disease status: healthy control CB2007224-C5.CEL health control 5
GSM799732
GPL570
health control 6 health control 6 tissue: peripheral blood cell type: lymphocytes disease status: healthy control CB2007224-C6.CEL health control 6
GSM799733
GPL570
health control 7 health control 7 tissue: peripheral blood cell type: lymphocytes disease status: healthy control CB2007224-C7.CEL health control 7
GSM799734
GPL570
health control 8 health control 8 tissue: peripheral blood cell type: lymphocytes disease status: healthy control CB2007224-C8.CEL health control 8
GSM799735
GPL570
SSD patient 10 before treatment SSD patient 10 before treatment tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: before treatment CB2007224-D10A.CEL MDD patient 10 before treatment with venlafaxine
GSM799736
GPL570
SSD patient 11 before treatment SSD patient 11 before treatment tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: before treatment CB2007224-D11A.CEL MDD patient 11 before treatment with venlafaxine
GSM799737
GPL570
SSD patient 11 after treatment with Venlafaxine SSD patient 11 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: after treatment with Venlafaxine CB2007224-D11B.CEL MDD patient 11 after treatment with Venlafaxine
GSM799738
GPL570
MDD patient 13 before treatment MDD patient 13 before treatment tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: before treatment CB2007224-D13A.CEL MDD patient 13 before treatment with venlafaxine
GSM799739
GPL570
MDD patient 13 after treatment with Venlafaxine MDD patient 13 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: after treatment with Venlafaxine CB2007224-D13B.CEL MDD patient 13 after treatment with Venlafaxine
GSM799740
GPL570
MDD patient 14 before treatment MDD patient 14 before treatment tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: before treatment CB2007224-D14A.CEL MDD patient 14 before treatment with venlafaxine
GSM799741
GPL570
MDD patient 14 after treatment with Venlafaxine MDD patient 14 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: after treatment with Venlafaxine CB2007224-D14B.CEL MDD patient 14 after treatment with Venlafaxine
GSM799742
GPL570
SSD patient 15 before treatment SSD patient 15 before treatment tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: before treatment CB2007224-D15A.CEL MDD patient 15 before treatment with venlafaxine
GSM799743
GPL570
MDD patient 19 before treatment MDD patient 19 before treatment tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: before treatment CB2007224-D19A.CEL MDD patient 19 before treatment with venlafaxine
GSM799744
GPL570
MDD patient 19 after treatment with Venlafaxine MDD patient 19 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: after treatment with Venlafaxine CB2007224-D19B.CEL MDD patient 19 after treatment with Venlafaxine
GSM799745
GPL570
MDD patient 1 after treatment with Venlafaxine MDD patient 1 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: after treatment with Venlafaxine CB2007224-D1B.CEL MDD patient 1 after treatment with Venlafaxine
GSM799746
GPL570
SSD patient 21 before treatment SSD patient 21 before treatment tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: before treatment CB2007224-D21A.CEL MDD patient 21 before treatment with venlafaxine
GSM799747
GPL570
SSD patient 21 after treatment with Venlafaxine SSD patient 21 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: after treatment with Venlafaxine CB2007224-D21B.CEL MDD patient 21 after treatment with Venlafaxine
GSM799748
GPL570
SSD patient 22 before treatment SSD patient 22 before treatment tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: before treatment CB2007224-D22A.CEL MDD patient 22 before treatment with venlafaxine
GSM799749
GPL570
SSD patient 22 after treatment with Venlafaxine SSD patient 22 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: after treatment with Venlafaxine CB2007224-D22B.CEL MDD patient 22 after treatment with Venlafaxine
GSM799750
GPL570
SSD patient 24 before treatment SSD patient 24 before treatment tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: before treatment CB2007224-D24A.CEL MDD patient 24 before treatment with venlafaxine
GSM799751
GPL570
SSD patient 29 after treatment with Venlafaxine SSD patient 29 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: after treatment with Venlafaxine CB2007224-D29-2.CEL MDD patient 29 after treatment with Venlafaxine
GSM799752
GPL570
SSD patient 29 before treatment SSD patient 29 before treatment tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: before treatment CB2007224-D29A.CEL MDD patient 29 before treatment with venlafaxine
GSM799753
GPL570
MDD patient 2 after treatment with Venlafaxine MDD patient 2 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: after treatment with Venlafaxine CB2007224-D2B.CEL MDD patient 2 after treatment with Venlafaxine
GSM799754
GPL570
SSD patient 30 before treatment SSD patient 30 before treatment tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: before treatment CB2007224-D30-1.CEL MDD patient 30 before treatment with venlafaxine
GSM799755
GPL570
SSD patient 30 after treatment with Venlafaxine SSD patient 30 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: SSD patient treatment: after treatment with Venlafaxine CB2007224-D30-2.CEL MDD patient 30 after treatment with Venlafaxine
GSM799756
GPL570
MDD patient 3 after treatment with Venlafaxine MDD patient 3 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: after treatment with Venlafaxine CB2007224-D3B.CEL MDD patient 3 after treatment with Venlafaxine
GSM799757
GPL570
MDD patient 4 after treatment with Venlafaxine MDD patient 4 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: after treatment with Venlafaxine CB2007224-D4B.CEL MDD patient 4 after treatment with Venlafaxine
GSM799758
GPL570
MDD patient 5 after treatment with Venlafaxine MDD patient 5 after treatment with Venlafaxine tissue: peripheral blood cell type: lymphocytes disease status: MDD patient treatment: after treatment with Venlafaxine CB2007224-D5B.CEL MDD patient 5 after treatment with Venlafaxine
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes